These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
284 related items for PubMed ID: 10792847
1. Binding of murine antibodies against whole-cell pertussis vaccine or filamentous haemagglutinin by Bordetella pertussis from patients with whooping cough. van den Berg BM, Beekhuizen H, Van Furth R, Mooi FR. Scand J Immunol; 2000 May; 51(5):530-2. PubMed ID: 10792847 [Abstract] [Full Text] [Related]
2. Immunogenicity and protective efficacy of a recombinant filamentous haemagglutinin from Bordetella pertussis. Knight JB, Huang YY, Halperin SA, Anderson R, Morris A, Macmillan A, Jones T, Burt DS, Van Nest G, Lee SF. Clin Exp Immunol; 2006 Jun; 144(3):543-51. PubMed ID: 16734625 [Abstract] [Full Text] [Related]
3. Serological correlates in whooping cough. Granström M, Granström G. Vaccine; 1993 Jun; 11(4):445-8. PubMed ID: 8470429 [Abstract] [Full Text] [Related]
7. Antigens in whooping cough vaccine and antibody levels induced by vaccination of children. Ashworth LA, Robinson A, Irons LI, Morgan CP, Isaacs D. Lancet; 1983 Oct 15; 2(8355):878-81. PubMed ID: 6137697 [Abstract] [Full Text] [Related]
9. Immunodominant domains present on the Bordetella pertussis vaccine component filamentous hemagglutinin. Leininger E, Bowen S, Renauld-Mongénie G, Rouse JH, Menozzi FD, Locht C, Heron I, Brennan MJ. J Infect Dis; 1997 Jun 15; 175(6):1423-31. PubMed ID: 9180182 [Abstract] [Full Text] [Related]
10. Protective effects of in vivo-expressed autotransporters against Bordetella pertussis infection. Suzuki K, Shinzawa N, Ishigaki K, Nakamura K, Abe H, Fukui-Miyazaki A, Ikuta K, Horiguchi Y. Microbiol Immunol; 2017 Sep 15; 61(9):371-379. PubMed ID: 28752940 [Abstract] [Full Text] [Related]
11. Eighty-kilodalton N-terminal moiety of Bordetella pertussis filamentous hemagglutinin: adherence, immunogenicity, and protective role. Alonso S, Reveneau N, Pethe K, Locht C. Infect Immun; 2002 Aug 15; 70(8):4142-7. PubMed ID: 12117922 [Abstract] [Full Text] [Related]
12. The seroepidemiology of Bordetella pertussis infections: a study of persons ages 1-65 years. Cattaneo LA, Reed GW, Haase DH, Wills MJ, Edwards KM. J Infect Dis; 1996 May 15; 173(5):1256-9. PubMed ID: 8627081 [Abstract] [Full Text] [Related]
13. Levels of anti-pertussis antibodies related to protection after household exposure to Bordetella pertussis. Storsaeter J, Hallander HO, Gustafsson L, Olin P. Vaccine; 1998 Dec 15; 16(20):1907-16. PubMed ID: 9796042 [Abstract] [Full Text] [Related]
14. Immunogenicity of an acellular pertussis vaccine composed of genetically inactivated pertussis toxin combined with filamentous hemagglutinin and pertactin in infants and children. Podda A, Carapella De Luca E, Titone L, Casadei AM, Cascio A, Bartalini M, Volpini G, Peppoloni S, Marsili I, Nencioni L. J Pediatr; 1993 Jul 15; 123(1):81-4. PubMed ID: 8320630 [Abstract] [Full Text] [Related]
15. Serum IgG antibody responses to pertussis toxin and filamentous hemagglutinin in nonvaccinated and vaccinated children and adults with pertussis. Trollfors B, Taranger J, Lagergård T, Sundh V, Bryla DA, Schneerson R, Robbins JB. Clin Infect Dis; 1999 Mar 15; 28(3):552-9. PubMed ID: 10194077 [Abstract] [Full Text] [Related]
17. History of whooping cough in nonvaccinated Swedish children, related to serum antibodies to pertussis toxin and filamentous hemagglutinin. Zackrisson G, Taranger J, Trollfors B. J Pediatr; 1990 Feb 15; 116(2):190-4. PubMed ID: 2299488 [Abstract] [Full Text] [Related]
18. Antibodies to filamentous hemagglutinin of Bordetella pertussis and protection against whooping cough in schoolchildren. He Q, Viljanen MK, Olander RM, Bogaerts H, De Grave D, Ruuskanen O, Mertsola J. J Infect Dis; 1994 Sep 15; 170(3):705-8. PubMed ID: 8077734 [Abstract] [Full Text] [Related]